{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:16:47Z","timestamp":1777551407285,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1023\/a:1016243313027","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T21:48:35Z","timestamp":1041112115000},"page":"275-283","source":"Crossref","is-referenced-by-count":45,"title":["Comparative Tissue Distribution and Elimination of Amphotericin B Colloidal Dispersion (Amphocil\u00ae) and Fungizone\u00ae After Repeated Dosing in Rats"],"prefix":"10.1007","volume":"12","author":[{"given":"Laurence H.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke S. S.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"307292_CR1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","volume":"12","author":"H. A. Gallis","year":"1990","unstructured":"H. A. Gallis, R. H. Drew, and W. W. Pickard. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12: 308\u2013329 (1990).","journal-title":"Rev. Infect. Dis."},{"key":"307292_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00325481.1990.11716368","volume":"88","author":"G. A. Sarosi.","year":"1990","unstructured":"G. A. Sarosi. Amphotericin B still the \u201cgold standard\u201d for antifungal therapy. Postgrad. Med. 88: 151\u2013166 (1990).","journal-title":"Postgrad. Med."},{"key":"307292_CR3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1749-6632.1985.tb18416.x","volume":"446","author":"R. L. Juliano","year":"1985","unstructured":"R. L. Juliano, G. Lopez-Berestein, R. Hopfer, R. Mehta, K. Mehta, and K. Mills. Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infections. Ann. N. Y. Acad. Sci. 446: 392\u2013402 (1985).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"307292_CR4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1164\/arrd.1982.125.5.610","volume":"125","author":"R. L. Taylor","year":"1982","unstructured":"R. L. Taylor, D. M. Williams, P. C. Craven, J. R. Graybill, and D. J. Drutz. Amphotericin B in liposomes: A novel therapy for histoplasmosis. Am Rev. Respir. Dis. 125: 610\u2013611 (1982).","journal-title":"Am Rev. Respir. Dis."},{"key":"307292_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/AAC.34.3.381","volume":"34","author":"J. Brajtburg","year":"1990","unstructured":"J. Brajtburg, W. G. Powderly, G. S. Kobayashi, and G. Medoff. Amphotericin B: delivery systems. Antimicrob. Agents Chemother. 34: 381\u2013384 (1990).","journal-title":"Antimicrob. Agents Chemother."},{"key":"307292_CR6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/AAC.35.4.615","volume":"35","author":"J. M. Clark","year":"1991","unstructured":"J. M. Clark, R. R. Whitney, S. J. Olsen, R. J. George, M. R. Swerdel, L. Kunselman, and D. P. Bonner. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob. Agents Chemother. 35: 615\u2013621 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"307292_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.2042-7158.1987.tb07156.x","volume":"39","author":"N. I. Payne","year":"1987","unstructured":"N. I. Payne, R. E. Crosgrove, A. P. Green, and L. Liu. In-vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice. J. Pharm. Pharmacol. 39: 24\u201328 (1987).","journal-title":"J. Pharm. Pharmacol."},{"key":"307292_CR8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1200\/JCO.1987.5.2.310","volume":"5","author":"G. Lopez-Berestein","year":"1987","unstructured":"G. Lopez-Berestein, G. P. Bodey, L. S. Frankel, and K. Mehta. Treatment of candidiasis with liposomal-amphotericin B. J. Clin. Oncol. 5: 310\u2013317 (1987).","journal-title":"J. Clin. Oncol."},{"key":"307292_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1399-0012.1990.tb00047.x","volume":"4","author":"J. Tollemar","year":"1990","unstructured":"J. Tollemar, O. Ringden, and G. Tyden. Liposomal amphotericin B (AmBisomeR) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation. Clin. Transplant. 4: 167\u2013175 (1990).","journal-title":"Clin. Transplant."},{"key":"307292_CR10","first-page":"563","volume":"25","author":"T. F. Patterson","year":"1990","unstructured":"T. F. Patterson and V. T. Andriole. The role of liposomal amphotericin B in the treatment of systemic fungal infections. Eur. J. Cancer Clin. Oncol. 25: 563\u2013568 (1990).","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"307292_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/28.suppl_B.49","volume":"28","author":"R. T. Proffitt","year":"1991","unstructured":"R. T. Proffitt, A. Satorius, S.-M. Chiang, L. Sullivan, and J. P. Adler-Moore. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J. Antimicrob. Chemother. 28(Suppl. B): 49\u201361 (1991).","journal-title":"J. Antimicrob. Chemother."},{"key":"307292_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/28.suppl_B.83","volume":"28","author":"F. Meunier","year":"1991","unstructured":"F. Meunier, H. G. Prentice, and O. Ringden. Liposomal amphotericin B (AmBisome): safety data from a phase II\/III clinical trial. J. Antimicorb. Chemother. 28(Suppl. B): 83\u201391 (1991).","journal-title":"J. Antimicorb. Chemother."},{"key":"307292_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(91)90249-N","volume":"75","author":"L. S. S. Guo","year":"1991","unstructured":"L. S. S. Guo, R. M. Fielding, D. D. Lasic, R. L. Hamilton and D. Mufson. Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discs. Int. J. Pharmaceutics 75: 45\u201354 (1991).","journal-title":"Int. J. Pharmaceutics"},{"key":"307292_CR14","unstructured":"R. M. Fielding, M. S. Newman, and L. S. S. Guo. Abtr. Am. Soc. Pharmacol. Exp. Ther. 41st Annual Meeting. Abstract No. 176 (1990)."},{"key":"307292_CR15","unstructured":"K. V. Clemons, A. M. Perlman, L. H. Hanson, and D. A. Stevens. Abtr. Int. Congr. infect. Dis. Abstract No. 389, p. 39 (1990)."},{"key":"307292_CR16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.35.6.1208","volume":"35","author":"R. M. Fielding","year":"1991","unstructured":"R. M. Fielding, P. C. Smith, L. H. Wang, J. Porter, and L. S. S. Guo. Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrob. Agents Chemother. 35: 1208\u20131213 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"307292_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/AAC.36.2.299","volume":"36","author":"R. M. Fielding","year":"1992","unstructured":"R. M. Fielding, A. W. Singer, L. H. Wang, S. Babbar, and L. S. S. Guo. Relationship of pharmacokinetics and tissue distribution to increased safety of colloidal amphotericin B in dogs. Antimicrob. Agents Chemother. 36: 299\u2013307 (1992).","journal-title":"Antimicrob. Agents Chemother."},{"key":"307292_CR18","first-page":"307","volume":"9","author":"A. C. Parekh","year":"1974","unstructured":"A. C. Parekh, R. J. Creno, and C. V. Dave. Hypocholesterolemic effect of amphotericin B: an analytical approach. Res. Commun. Chem. Pathol. Pharmacol. 9: 307\u2013314 (1974).","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"307292_CR19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jps.2600720503","volume":"72","author":"D. M. Cocchetto","year":"1983","unstructured":"D. M. Cocchetto and T. Bjornsson. Methods for vascular access and collection of body fluids from the laboratory rat. J. Pharm. Sci. 72: 465\u2013492 (1983).","journal-title":"J. Pharm. Sci."},{"key":"307292_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-4347(92)80390-C","volume":"579","author":"L. H. Wang","year":"1992","unstructured":"L. H. Wang, P. C. Smith, K. L. Anderson, and R. M. Fielding. HPLC analysis of amphotericin B in plasma, blood, urine, and tissues for pharmacokinetic and tissue distribution studies. J. Chromatogr. 579: 259\u2013268 (1992).","journal-title":"J. Chromatogr."},{"key":"307292_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jps.2600730239","volume":"73","author":"I. L. Smith","year":"1984","unstructured":"I. L. Smith and J. J. Schentag. Noncompartmental determination of the steady-state volume of distribution during multiple dosing. J. Pharm. Sci. 73: 281\u2013282 (1984).","journal-title":"J. Pharm. Sci."},{"key":"307292_CR22","first-page":"19","volume-title":"The Clinical Chemistry of Laboratory Animals","author":"R. G. Meeks.","year":"1989","unstructured":"R. G. Meeks. The rat. In W. F. Loeb and F. W. Quimby (eds.) The Clinical Chemistry of Laboratory Animals, Pergamon Press, New York, Chapter 2, p. 19\u201325 (1989)."},{"key":"307292_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/cdd.1984.1.199","volume":"1","author":"G. Lopez-Berestein","year":"1984","unstructured":"G. Lopez-Berestein, M. Rosenblem, and R. Mehta. Altered tissue distribution of amphotericin B by liposomal encapsulation: Comparison of normal mice to mice infected with Candida albicans. Cancer Drug Delivery 1: 199\u2013205 (1984).","journal-title":"Cancer Drug Delivery"},{"key":"307292_CR24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.31.3.421","volume":"31","author":"F. C. Szoka","year":"1987","unstructured":"F. C. Szoka, D. Milholland, and M. Barza. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob. Agents Chemother. 31: 421\u2013429 (1987).","journal-title":"Antimicrob. Agents Chemother."},{"key":"307292_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00007691-198905000-00015","volume":"11","author":"L. E. Edmonds","year":"1989","unstructured":"L. E. Edmonds, L. Davidson, and J. S. Bertino. Solubility and stability of amphotericin B in human serum. Ther. Drug Monit. 11: 323\u2013326 (1989).","journal-title":"Ther. Drug Monit."},{"key":"307292_CR26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-80-5-613","volume":"80","author":"E. D. Block","year":"1974","unstructured":"E. D. Block, J. E. Bennel, L. G. Livoti, W. J. Klein, R. R. MacGregor, and L. Henderson. Flucytosine and amphotericin B: Hemodialysis effects on the plasma concentration and clearance. Ann. Int. Med. 80: 613\u2013617 (1974).","journal-title":"Ann. Int. Med."},{"key":"307292_CR27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/infdis\/159.4.717","volume":"159","author":"T. Patterson","year":"1989","unstructured":"T. Patterson, P. Miniter, J. Dijkstra, F. Szoka, J. Ryan, and V. Andriole. Treatment of experimental invasive aspergillosis with novel amphotericin B\/Cholesterol-sulfate complexes. J. Infect. Dis. 159: 717\u2013724 (1989).","journal-title":"J. Infect. Dis."},{"key":"307292_CR28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/infdis\/140.3.329","volume":"140","author":"P. C. Craven","year":"1979","unstructured":"P. C. Craven, T. M. Ludden, D. J. Drutz, W. Rogers, K. A. Haegele, and H. B. Skrdlant. Excretion pathways of amphotericin B. J. Infect. Dis. 140: 329\u2013341 (1979).","journal-title":"J. Infect. Dis."},{"key":"307292_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jac\/6.2.241","volume":"6","author":"R. Lawrence","year":"1980","unstructured":"R. Lawrence, P. Hoepich, F. Jagdis, N. Monji, A. Huston, and C. Schaffner. Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B. J. Antimicrob. Chemother. 6: 241\u2013249 (1980).","journal-title":"J. Antimicrob. Chemother."},{"key":"307292_CR30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.26.4.446","volume":"26","author":"H. Kim","year":"1984","unstructured":"H. Kim, D. Loebenberg, A. Marco, S. Symchowicz, and C. Lin. Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and Cynomoigus monkeys, Antimicrob. Agents Chemother. 26: 446\u2013449 (1984).","journal-title":"Agents Chemother."},{"key":"307292_CR31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0732-8893(83)90011-1","volume":"1","author":"W. H. Beggs.","year":"1983","unstructured":"W. H. Beggs. Antioxidant stabilized amphotericin B. Diagn. Microbiol. Infect. Dis. 1: 339\u2013341 (1983).","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016243313027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1016243313027\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016243313027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:11:35Z","timestamp":1754028695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1016243313027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["307292"],"URL":"https:\/\/doi.org\/10.1023\/a:1016243313027","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}